MCK|Mckesson Corp|Price:948.680|Chg%:-9.20

More Details of Mckesson Corp Company

McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.

Mckesson Corp Info



Ticker SymbolMCK

Company nameMcKesson Corp

IPO dateNov 10, 1994

CEOTyler (Brian Scott)

Number of employees43000

Security typeOrdinary Share

Fiscal year-endNov 10

Address6555 State Highway 161

CityIRVING

Stock exchangeNASDAQ OMX NASDAQ Basic NYSE

CountryUnited States of America

Postal code75039

Phone19724464800

Websitehttps://www.mckesson.com/

Ticker SymbolMCK

IPO dateNov 10, 1994

CEOTyler (Brian Scott)

Company Executives of Mckesson Corp



Name

Name/Position

Position

Shareholding

Change

Mr. Britt J. Vitalone

Chief Financial Officer, Executive Vice President

14.58K

+2.00%

Mr. Brian Scott Tyler, Ph.D.

Chief Executive Officer, Director

4.23K

-23860.00%

Ms. Michele Lau

Executive Vice President, Chief Legal Officer

3.38K

+439.00%

Mr. Thomas L. (Tom) Rodgers

Executive Vice President, Chief Strategy and Business Development Officer

2.27K

-276.00%

Mr. Donald R. (Don) Knauss

Independent Chairman of the Board

2.07K

--

Mr. Dominic J. Caruso

Independent Director

650.00

+301.00%

Ms. Kathleen Wilson - Thompson

Independent Director

301.00

+301.00%

Mr. Bradley E. (Brad) Lerman

Independent Director

--

Ms. Maria N. Martinez

Independent Director

--

Mr. James H. Hinton

Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Mr. Britt J. Vitalone

Chief Financial Officer, Executive Vice President

14.58K

+2.00%

Mr. Brian Scott Tyler, Ph.D.

Chief Executive Officer, Director

4.23K

-23860.00%

Ms. Michele Lau

Executive Vice President, Chief Legal Officer

3.38K

+439.00%

Mr. Thomas L. (Tom) Rodgers

Executive Vice President, Chief Strategy and Business Development Officer

2.27K

-276.00%

Mr. Donald R. (Don) Knauss

Independent Chairman of the Board

2.07K

--

Mr. Dominic J. Caruso

Independent Director

650.00

+301.00%

Revenue Breakdown

Currency: USDUpdated: Fri, Feb 21

FY2020

FY2019

Relevant data have not been disclosed by the company yet.

By RegionUSD

Name

Revenue

Proportion

United States

192.71B

83.41%

Foreign

38.34B

16.59%

By Business

By Region

Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sat, Nov 15

Shareholders

Shareholder Types

Shareholders

Proportion

The Vanguard Group, Inc.

9.83%

BlackRock Institutional Trust Company, N.A.

5.54%

State Street Investment Management (US)

4.69%

MFS Investment Management

2.75%

Geode Capital Management, L.L.C.

2.31%

Other

74.86%

Shareholders

Proportion

The Vanguard Group, Inc.

9.83%

BlackRock Institutional Trust Company, N.A.

5.54%

State Street Investment Management (US)

4.69%

MFS Investment Management

2.75%

Geode Capital Management, L.L.C.

2.31%

Other

74.86%

Shareholder Types

Shareholders

Proportion

Investment Advisor

47.99%

Investment Advisor/Hedge Fund

31.98%

Pension Fund

3.22%

Research Firm

2.74%

Bank and Trust

2.01%

Hedge Fund

1.93%

Sovereign Wealth Fund

1.60%

Family Office

0.41%

Family Office

0.41%

Other

7.70%

Institutional Shareholding



Updated: Thu, Jan 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q4

3060

112.33M

91.01%

-3.78M

2025Q3

2930

112.70M

90.60%

-2.26M

2025Q2

2898

111.75M

89.83%

-2.74M

2025Q1

2904

112.96M

90.43%

-4.50M

2024Q4

2760

112.22M

89.53%

-6.16M

2024Q3

2646

112.88M

88.88%

-6.35M

2024Q2

2612

114.72M

88.46%

-4.02M

2024Q1

2547

114.60M

88.11%

-6.25M

2023Q4

2490

116.65M

88.75%

-6.75M

2023Q3

2349

117.73M

88.45%

-6.84M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

11.97M

9.7%

-42.57K

-0.35%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

6.79M

5.5%

+50.94K

+0.76%

Sep 30, 2025

State Street Investment Management (US)

5.75M

4.66%

+51.51K

+0.90%

Sep 30, 2025

MFS Investment Management

3.85M

3.12%

-69.77K

-1.78%

Sep 30, 2025

Geode Capital Management, L.L.C.

2.83M

2.29%

+11.54K

+0.41%

Sep 30, 2025

Fidelity Management & Research Company LLC

2.74M

2.22%

+832.12K

+43.63%

Sep 30, 2025

AllianceBernstein L.P.

2.39M

1.94%

+126.68K

+5.59%

Sep 30, 2025

Putnam Investment Management, L.L.C.

2.35M

1.9%

+82.02K

+3.62%

Sep 30, 2025

Norges Bank Investment Management (NBIM)

1.84M

1.49%

-268.49K

-12.75%

Jun 30, 2025

JP Morgan Asset Management

1.68M

1.36%

-1.77M

-51.21%

Sep 30, 2025

Related ETFs



Updated: Sat, Dec 6

Name

Proportion

VanEck Pharmaceutical ETF

10.76%

NestYield Total Return Guard ETF

10%

VanEck Retail ETF

5.01%

Texas Capital Texas Equity Index ETF

4.71%

iShares US Consumer Staples ETF

4.4%

First Trust Consumer Staples Alphadex Fund

4.28%

Alger 35 ETF

4.1%

Putnam Focused Large Cap Value ETF

3.46%

SEI Enhanced Low Volatility US Large Cap ETF

2.68%

JPMorgan Healthcare Leaders ETF

2.6%

VanEck Pharmaceutical ETF

Proportion10.76%

NestYield Total Return Guard ETF

Proportion10%

VanEck Retail ETF

Proportion5.01%

Texas Capital Texas Equity Index ETF

Proportion4.71%

iShares US Consumer Staples ETF

Proportion4.4%

First Trust Consumer Staples Alphadex Fund

Proportion4.28%

Alger 35 ETF

Proportion4.1%

Putnam Focused Large Cap Value ETF

Proportion3.46%

SEI Enhanced Low Volatility US Large Cap ETF

Proportion2.68%

JPMorgan Healthcare Leaders ETF

Proportion2.6%

Dividend



A total of 1.50B USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Jan 28, 2026

MCK.NB Final Cash Dividend of gross USD 0.82 paid on Apr 01, 2026 going ex on Mar 02, 2026

Mar 02, 2026

Apr 01, 2026

Mar 02, 2026

Oct 30, 2025

MCK.NB Interim Cash Dividend of gross USD 0.82 paid on Jan 02, 2026 going ex on Dec 01, 2025

Dec 01, 2025

Jan 02, 2026

Dec 01, 2025

Jul 30, 2025

MCK.NB Interim Cash Dividend of gross USD 0.82 paid on Oct 01, 2025 going ex on Sep 02, 2025

Sep 02, 2025

Oct 01, 2025

Sep 02, 2025

May 01, 2025

MCK.NB Interim Cash Dividend of gross USD 0.71 paid on Jul 01, 2025 going ex on Jun 02, 2025

Jun 02, 2025

Jul 01, 2025

Jun 02, 2025

Jan 30, 2025

MCK.NB Final Cash Dividend of gross USD 0.71 paid on Apr 01, 2025 going ex on Mar 03, 2025

Mar 03, 2025

Apr 01, 2025

Mar 03, 2025

Oct 31, 2024

MCK.NB Interim Cash Dividend of gross USD 0.71 paid on Jan 02, 2025 going ex on Dec 02, 2024

Dec 02, 2024

Jan 02, 2025

Dec 02, 2024

Aug 01, 2024

MCK.NB Interim Cash Dividend of gross USD 0.71 paid on Oct 01, 2024 going ex on Aug 30, 2024

Sep 02, 2024

Oct 01, 2024

Aug 30, 2024

Apr 24, 2024

MCK.NB Interim Cash Dividend of gross USD 0.62 paid on Jul 01, 2024 going ex on Jun 03, 2024

Jun 03, 2024

Jul 01, 2024

Jun 03, 2024

Feb 01, 2024

MCK.NB Final Cash Dividend of gross USD 0.62 paid on Apr 01, 2024 going ex on Feb 29, 2024

Mar 01, 2024

Apr 01, 2024

Feb 29, 2024

Oct 26, 2023

MCK.NB Interim Cash Dividend of gross USD 0.62 paid on Jan 02, 2024 going ex on Nov 30, 2023

Dec 01, 2023

Jan 02, 2024

Nov 30, 2023

Stock Splits



Date

Ex-dividend Date

Type

Ratio

No Data

Date

Ex-dividend Date

Type

Ratio

No Data